Patents by Inventor Jennifer J. Dowhanick-Morrissette

Jennifer J. Dowhanick-Morrissette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7423138
    Abstract: By virtue of the present invention, there is provided methods and compositions for interfering with the proliferation of cells infected and/or transformed by papillomaviruses. The processes and compositions of this invention may be used to treat any mammal, including humans. According to this invention, mammals are treated by the pharmaceutically acceptable administration of an E2ad/db protein, either directly or by gene transfer techniques, to reduce the symptoms of the specific papillomavirus-associated disease, or to prevent their recurrence.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: September 9, 2008
    Assignee: President and Fellows of Harvard College
    Inventors: Peter M. Howley, Jennifer J. Dowhanick-Morrissette, John D. Benson, Hiroyuki Sakai
  • Publication number: 20030092660
    Abstract: By virtue of the present invention, there is provided methods and compositions for interfering with the proliferation of cells infected and/or transformed by papillomaviruses. The processes and compositions of this invention may be used to treat any mammal, including humans. According to this invention, mammals are treated by the pharmaceutically acceptable administration of an E2ad/db protein, either directly or by gene transfer techniques, to reduce the symptoms of the specific papillomavirus-associated disease, or to prevent their recurrence.
    Type: Application
    Filed: July 1, 2002
    Publication date: May 15, 2003
    Inventors: Peter M. Howley, Jennifer J. Dowhanick-Morrissette, John D. Benson, Hiroyuki Sakai
  • Patent number: 6432926
    Abstract: By virtue of the present invention, there is provided methods and compositions for interfering with the proliferation of cells infected and/or transformed by papillomaviruses. The processes and compositions of this invention may be used to treat any mammal, including humans. According to this invention, mammals are treated by the pharmaceutically acceptable administration of an E2ad/db protein, either directly or by gene transfer techniques, to reduce the symptoms of the specific papillomavirus-associated disease, or to prevent their recurrence.
    Type: Grant
    Filed: July 27, 1999
    Date of Patent: August 13, 2002
    Assignee: President and Fellows of Harvard College
    Inventors: Peter M. Howley, Jennifer J. Dowhanick-Morrissette, John D. Benson, Hiroyuki Sakai